These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 33546219)

  • 1. The Role of Hypothalamic Inflammation in Diet-Induced Obesity and Its Association with Cognitive and Mood Disorders.
    Dionysopoulou S; Charmandari E; Bargiota A; Vlahos N; Mastorakos G; Valsamakis G
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33546219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways linking obesity to neuropsychiatric disorders.
    Martins LB; Monteze NM; Calarge C; Ferreira AVM; Teixeira AL
    Nutrition; 2019 Oct; 66():16-21. PubMed ID: 31200298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
    Soria V; González-Rodríguez A; Huerta-Ramos E; Usall J; Cobo J; Bioque M; Barbero JD; García-Rizo C; Tost M; Monreal JA; ; Labad J
    Psychoneuroendocrinology; 2018 Jul; 93():8-19. PubMed ID: 29680774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.
    Raber J
    Mol Neurobiol; 1998 Aug; 18(1):1-22. PubMed ID: 9824846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin's Role in the Hypothalamic-Pituitary-Adrenal Axis Stress Response: Implications for Mood Disorders.
    Spencer SJ; Emmerzaal TL; Kozicz T; Andrews ZB
    Biol Psychiatry; 2015 Jul; 78(1):19-27. PubMed ID: 25534754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future therapeutic targets in mood disorders: the glucocorticoid receptor.
    McQuade R; Young AH
    Br J Psychiatry; 2000 Nov; 177():390-5. PubMed ID: 11059990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenal axis in HIV infection and disease.
    Chrousos GP; Zapanti ED
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):791-806. PubMed ID: 25169568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease.
    Bose M; Oliván B; Laferrère B
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):340-6. PubMed ID: 19584720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological functioning in health and mood disorder: Modulation by glucocorticoids and their receptors.
    Gallagher P; Reid KS; Ferrier IN
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S196-207. PubMed ID: 19541428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of physical exercise on traumatic brain injury deficits: scaffolding effect.
    Archer T
    Neurotox Res; 2012 May; 21(4):418-34. PubMed ID: 22183422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis dysfunction during sleep in nocturnal asthma.
    Sutherland ER; Kraft M; Rex MD; Ellison MC; Martin RJ
    Chest; 2003 Mar; 123(3 Suppl):405S. PubMed ID: 12629004
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice.
    Müller MB; Uhr M; Holsboer F; Keck ME
    Neuroendocrinology; 2004 Jan; 79(1):1-12. PubMed ID: 14755129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.
    Fassbender K; Schmidt R; Mössner R; Kischka U; Kühnen J; Schwartz A; Hennerici M
    Arch Neurol; 1998 Jan; 55(1):66-72. PubMed ID: 9443712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
    Keller J; Gomez R; Williams G; Lembke A; Lazzeroni L; Murphy GM; Schatzberg AF
    Mol Psychiatry; 2017 Apr; 22(4):527-536. PubMed ID: 27528460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.
    Soczynska JK; Kennedy SH; Woldeyohannes HO; Liauw SS; Alsuwaidan M; Yim CY; McIntyre RS
    Neuromolecular Med; 2011 Jun; 13(2):93-116. PubMed ID: 21165712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can variation in hypothalamic-pituitary-adrenal (HPA)-axis activity explain the relationship between depression and cognition in bipolar patients?
    van der Werf-Eldering MJ; Riemersma-van der Lek RF; Burger H; Holthausen EA; Aleman A; Nolen WA
    PLoS One; 2012; 7(5):e37119. PubMed ID: 22606339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
    Reynolds RM
    Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression.
    Glynn LM; Davis EP; Sandman CA
    Neuropeptides; 2013 Dec; 47(6):363-70. PubMed ID: 24210135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.